Management of Renal Cell Carcinoma With Supradiaphragmatic Inferior Vena Cava Thrombus Diagnosed During Acute COVID-19 Infection
Michael Leyderman(Rutgers, The State University of New Jersey), Vignesh T. Packiam(Rutgers, The State University of New Jersey), Saum Ghodoussipour(Rutgers, The State University of New Jersey), Ian M. McElree(Vanderbilt University Medical Center), Yousef Zakharia(University of Iowa), Kenneth G. Nepple(University of Iowa)
Cited by 0
Related Papers
Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial
|The Lancet Oncology|2021|411
Comparison of Sequential Intravesical Gemcitabine and Docetaxel vs Bacillus Calmette-Guérin for the Treatment of Patients With High-Risk Non–Muscle-Invasive Bladder Cancer
|JAMA Network Open|2023|116
Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma: A Response-Based Phase II Study (OMNIVORE)
|Journal of Clinical Oncology|2020|105